Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study.

por Naguib, R. N., Robinson, M. C., Neal, D. E., Hamdy, F. C.
Publicado 1998

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

por Groselj, B, Sharma, N L, Hamdy, F C, Kerr, M, Kiltie, A E
Publicado 2013

Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.

por Fadlon, E. J., Rees, R. C., McIntyre, C., Sharrard, R. M., Lawry, J., Hamdy, F. C.
Publicado 1996

FGF8 isoform b expression in human prostate cancer

por Gnanapragasam, V J, Robinson, M C, Marsh, C, Robson, C N, Hamdy, F C, Leung, H Y
Publicado 2003

Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia.

por Bentley, H., Hamdy, F. C., Hart, K. A., Seid, J. M., Williams, J. L., Johnstone, D., Russell, R. G.
Publicado 1992

Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

por Autzen, P., Robson, C. N., Bjartell, A., Malcolm, A. J., Johnson, M. I., Neal, D. E., Hamdy, F. C.
Publicado 1998

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer

por Calvert, N W, Morgan, A B, Catto, J W F, Hamdy, F C, Akehurst, R L, Mouncey, P, Paisley, S
Publicado 2003

Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer

por Rao, S R, Snaith, A E, Marino, D, Cheng, X, Lwin, S T, Orriss, I R, Hamdy, F C, Edwards, C M
Publicado 2017

Changes in circulating microRNA levels associated with prostate cancer

por Bryant, R J, Pawlowski, T, Catto, J W F, Marsden, G, Vessella, R L, Rhees, B, Kuslich, C, Visakorpi, T, Hamdy, F C
Publicado 2012

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer

por Miah, S, Dudziec, E, Drayton, R M, Zlotta, A R, Morgan, S L, Rosario, D J, Hamdy, F C, Catto, J W F
Publicado 2012

Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer

por Mathew, G., Mitchell, A., Down, J. M., Jacobs, L. A., Hamdy, F. C., Eaton, C., Rosario, D. J., Cross, S. S., Winder, S. J.
Publicado 2013

Label-free Quantitative Proteomics Reveals Differentially Regulated Proteins Influencing Urolithiasis

por Wright, C. A., Howles, S., Trudgian, D. C., Kessler, B. M., Reynard, J. M., Noble, J. G., Hamdy, F. C., Turney, B. W.
Publicado 2011

bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer.

por Apakama, I., Robinson, M. C., Walter, N. M., Charlton, R. G., Royds, J. A., Fuller, C. E., Neal, D. E., Hamdy, F. C.
Publicado 1996

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors

por Rehman, I, Cross, S S, Azzouzi, A-R, Catto, J W F, Deloulme, J C, Larre, S, Champigneuille, J, Fromont, G, Cussenot, O, Hamdy, F C
Publicado 2004

Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.

por Hamdy, F. C., Fadlon, E. J., Cottam, D., Lawry, J., Thurrell, W., Silcocks, P. B., Anderson, J. B., Williams, J. L., Rees, R. C.
Publicado 1994

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

por Dimitropoulou, P, Martin, R M, Turner, E L, Lane, J A, Gilbert, R, Davis, M, Donovan, J L, Hamdy, F C, Neal, D E
Publicado 2011

The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer

por Desgrandchamps, F, Teren, M, Cortivo, L Dal, Marolleau, J-P, Bertheau, P, Villette, J-M, Cortesse, A, Teillac, P, Duc, A Le, Hamdy, F C
Publicado 1999

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcome...

por Sanghera, S., Mohiuddin, S., Coast, J., Garfield, K., Noble, S., Metcalfe, C., Lane, J. A., Turner, E. L., Neal, D., Hamdy, F. C., Martin, R. M., Donovan, J. L.
Publicado 2020

Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

por Gunnell, D, Oliver, S E, Peters, T J, Donovan, J L, Persad, R, Maynard, M, Gillatt, D, Pearce, A, Hamdy, F C, Neal, D E, Holly, J M P
Publicado 2003

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

por Macefield, R C, Metcalfe, C, Lane, J A, Donovan, J L, Avery, K N L, Blazeby, J M, Down, L, Neal, D E, Hamdy, F C, Vedhara, K
Publicado 2010